BlueReg

BlueReg is a leading strategic consultancy specializing in regulatory affairs, pharmacovigilance, and quality compliance for the life sciences industry. Founded in 2011 and headquartered in France, the company provides comprehensive support throughout the entire drug development lifecycle, from initial clinical trial applications to marketing authorization and post-market surveillance. Their expertise spans global markets, including the European Union and the United States, offering specialized guidance on complex regulatory pathways and market access strategies. In 2022, BlueReg was acquired by PharmaLex, integrating its specialized services into a broader global platform under the Cencora umbrella. The firm serves a diverse client base ranging from small biotech startups to large multinational pharmaceutical corporations.